Showing results (31-40 of 47) with videos related to
Sort By:
Pageof 5
Peptides|January 1, 1996
In vitro and in vivo biological activities of PG-KII, a novel kassinin-like peptide from the skin of the Australian frog, Pseudophryne güntheriG Improta, M Broccardo, C Severini, et al.Peptides|May 8, 2012
TLQP-21, a VGF-derived peptide, stimulates exocrine pancreatic secretion in the ratC Petrella, M Broccardo, R Possenti, et al.Peptides|March 9, 2004
Stimulatory effect of PG-KII, an NK3 tachykinin receptor agonist, on isolated pancreatic acini: species-related differencesG Linari, G Improta, S Agostini, et al.Neurogastroenterology and Motility|April 16, 2008
Central and peripheral role of the nociceptin/orphaninFQ system on normal and disturbed colonic motor function and faecal pellet output in the ratM Broccardo, S Agostini, C Petrella, et al.Peptides|August 23, 2005
The effects of [Arg14, Lys15] nociceptin/orphanin FQ, a highly potent agonist of the NOP receptor, on in vitro and in vivo gastrointestinal functionsM Broccardo, G Linari, R Guerrini, et al.British Journal of Pharmacology|October 1, 1975
Relative potency of bombesin-like peptidesM Broccardo, G Falconieri Erspamer, P Melchiorri, et al.Neurogastroenterology and Motility|December 13, 2005
Nociceptin/orphanin FQ-induced delay in gastric emptying: role of central corticotropin-releasing factor and glucocorticoid receptorsM Broccardo, S Scaccianoce, P Del Bianco, et al.Peptides|September 4, 2007
The gastric effects of UFP-112, a new nociceptin/orphanin receptor agonist, in physiological and pathological conditionsM Broccardo, R Guerrini, G Morini, et al.Peptides|January 1, 1997
Further evidence that the tachykinin PG-KII is a potent agonist at central NK-3, but not NK-1, receptorsC Polidori, I Panocka, R Ciccocioppo, et al.Chirurgia Italiana|April 1, 1984
[Prevention of gastroesophageal reflux. Validity of hemifundoplication according to Cor-Casolo (experimental study)]S Monni, R Roddi, V Melita, et al.Pageof 5